JOHANNESBURG (Reuters) -Africa’s prime public well being physique stated on Thursday it had signed a memorandum of understanding with Pfizer for nations on the continent to obtain provides of the Paxlovid tablet to deal with COVID-19.
Information from a mid-to-late stage examine in November final 12 months confirmed the antiviral remedy was almost 90% efficient in stopping hospitalisations and deaths in comparison with a placebo, in adults at excessive threat of extreme sickness.
“Now we have signed the MOU with Pfizer and we’re going to have the ability to make that individual therapy accessible to African nations,” stated Ahmed Ogwell Ouma, appearing director of the Africa Centres for Illness Management and Prevention.
Ouma stated the MOU would enable African nations to entry Paxlovid at price.
The Africa CDC, which is an company of the 55-member African Union, had stated in March the MOU was prepared, however wanted to be cleared by its authorized workplace.
(Reporting by Anait Miridzhanian and James Macharia ChegeEditing by Estelle Shirbon)
